Roger Jeffs - 14 Dec 2023 Form 4 Insider Report for Liquidia Corp (LQDA)

Role
Chief Executive Officer, Director
Signature
/s/ Roger Jeffs
Issuer symbol
LQDA
Transactions as of
14 Dec 2023
Net transactions value
+$1,000,001
Form type
4
Filing time
18 Dec 2023, 17:02:01 UTC
Previous filing
06 Jun 2023
Next filing
16 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LQDA Common Stock Purchase $1,000,001 +139,665 +28% $7.16 640,805 14 Dec 2023 Direct F1, F2
holding LQDA Common Stock 46,595 14 Dec 2023 See footnote F3
holding LQDA Common Stock 1,541,667 14 Dec 2023 See footnote F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Issuer common stock purchased by the Reporting Person pursuant to that certain Common Stock Purchase Agreement, dated as of December 14, 2023, by and among the Issuer and the Reporting Person.
F2 Includes 5,384 shares acquired under the Liquidia Corporation 2020 Employee Stock Purchase Plan.
F3 The securities are held by Roger A. Jeffs Living Trust UAD 2/29/2000 (the "Trust"). The Reporting Person is the trustee of the Trust.
F4 The securities are held by Serendipity BioPharma LLC ("Serendipity"). The Reporting Person is a manager of Serendipity and has sole voting and dispositive power over the Issuer common stock held by Serendipity.